Biodizine as a civilizational challenge of modern pharmaceuticals

Alexander I. Tyukavin , Nikolay А. Arseniev , Maria A. Studneva , Veronika S. Medvedeva , Sergey V. Suchkov

Pharmacy Formulas ›› 2021, Vol. 3 ›› Issue (4) : 108 -117.

PDF
Pharmacy Formulas ›› 2021, Vol. 3 ›› Issue (4) :108 -117. DOI: 10.17816/phf99672
Actual problems: discussion tribune
review-article

Biodizine as a civilizational challenge of modern pharmaceuticals

Author information +
History +
PDF

Abstract

The review discusses the role of pharmaceutical and drug design methodology in the development of the high-tech segment of the development and production of original drugs for personalized and precision medicine (PPM). Topical issues of using predictively personalized tools for precision medicine in pharmaceuticals are highlighted. New opportunities and prospects for increasing the effectiveness of drugs in various fields of medicine created on the basis of pharmaceutical design are shown. Discussed are original approaches to standardization and reproducibility of the effects of new drugs at the preclinical stage using microfluidic bioconstructs – organ-on-a-chip systems. The relevance of improving university curricula for training specialists in the field of molecular drug design (drug design), harmonized with dynamically developing biotechnologies in pharmaceuticals, as well as the needs of domestic healthcare in original medicines for PPM, is shown.

Keywords

biopharmaceuticals / pharmdesign / personalized medicines / pharmaceutical design of preclinical studies / organ-on-a-chip system / training programs for drug- and pharmaceutical designers

Cite this article

Download citation ▾
Alexander I. Tyukavin, Nikolay А. Arseniev, Maria A. Studneva, Veronika S. Medvedeva, Sergey V. Suchkov. Biodizine as a civilizational challenge of modern pharmaceuticals. Pharmacy Formulas, 2021, 3(4): 108-117 DOI:10.17816/phf99672

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Suchkova S. V., ed. Osnovy personalizirovannoj i precizionnoj mediciny. Uchebnik dlja medicinskih vuzov i fakul’tetov Kazan: ID MedDok; 2021. 628 p. (In Russ.).

[2]

Основы персонализированной и прецизионной медицины. Учебник для медицинских вузов и факультетов / под редакцией С. В. Сучкова. – Казань: ИД МедДок, 2021. – 628 с.

[3]

Tyukavin A. I., ed. Patologija: uchebnik. Moscow: INFRA-M; 2021. 844 p. (In Russ.).

[4]

Патология: учебник / под редакцией А. И. Тюкавина. – Москва: ИНФРА-М, 2021. – 844 с.

[5]

Chaplenko A. A., Vlasov V. V., Gildeeva G. N. Innovative medicines on the Russian pharmaceutical market: key players and main directions of development. Remedium. 2020;(10):4–9. https://doi.org/10.21518/1561-5936-2020-10-4-9 (In Russ.).

[6]

Чапленко А. А. Инновационные лекарственные препараты на российском фармацевтическом рынке: ключевые игроки и основные направления разработок / А. А. Чапленко, В. В. Власов, Г. Н. Гильдеева // Ремедиум. – 2020. – № 10. – С. 4–9. https://doi.org/10.21518/1561-5936-2020-10-4-9

[7]

The Pharma Media: BioMedTracker and Cortellis databases.

[8]

The Pharma Media: базы данных BioMedTracker и Cortellis.

[9]

Okminyan G. F., Latyshev O. Yu., Kiseleva E. V., et al. Basal insulin evolution: from simple to more complex. Endokrinologiya: novosti, mneniya, obuchenie = Endocrinology: News, Opinions, Training. 2021;10(1):18–25. https://doi.org/10.33029/2304-9529-2021-10-1-18-25 (In Russ.).

[10]

Окминян Г. Ф. Эволюция препаратов базального инсулина: от простого к сложному / Г. Ф. Окминян, О. Ю. Латышев, Е. В. Киселева [и др.] // Эндокринология: новости, мнения, обучение. – 2021. – Т. 10. – № 1. – C. 18–25. https://doi.org/10.33029/2304-9529-2021-10-1-18-25

[11]

Dedov I. I., Peterkova V. A., Kuraeva T. L., et al. Insulinovaja pompa (pomoshh’ vrachu dlja jeffektivnogo upravlenija diabetom. Moscow; 2014. 126 p.

[12]

Дедов И. И. Инсулиновая помпа (помощь врачу для эффективного управления диабетом) / И. И. Дедов, В. А. Петеркова, Т. Л. Кураева [и др.]. – Москва, 2014. – 126 с.

[13]

Green A., Silver P., Collins J., et al. Toehold Switches: De-Novo-Designed Regulators of Gene Expression. Cell. 2014;159(4):925–939. http://dx.doi.org/10.1016/j.cell.2014.10.002

[14]

Green A., Silver P., Collins J., et al. Toehold Switches: De-Novo-Designed Regulators of Gene Expression // Cell. 2014. Vol. 159, no. 4. P. 925–939. http://dx.doi.org/10.1016/j.cell.2014.10.002

[15]

Belousov K. I., Evtrapov A. A., Kuhtevich I. V., et al. Osnovy nanotehnologij. Chast’ 2. Kapel’naja mikrofljuidika. Uchebnoe posobie. Saint Petersburg: ITMO University; 2015. 56 p.

[16]

Белоусов К. И. Основы нанотехнологий. Часть 2. Капельная микрофлюидика. Учебное пособие / К. И. Белоусов, А. А. Евстрапов, И. В. Кухтевич [и др.]. – Санкт-Петербург: Университет ИТМО, 2015. – 56 с.

[17]

Afonicheva P. K., Bulyanitsa A. L., Evstrapov A. A. «Organ-on-a-chip» – materials and methods of creation. Nauchnoe priborostroenie = Scientific Instrumentation. 2019;29(4):3–18.

[18]

Афоничева П. К. “Орган на чипе” – материал и методы / П. К. Афоничева, А. Л. Буляцина, А. А. Евстрапов // Научное приборостроение. – 2019. – Т. 29. – № 4. – С. 3–18.

[19]

Gijzen L., Marescotti D., Raineri E., et. al. An Intestine-on-a-Chip Model of Plug-and-Play Modularity to Study Inflammatory Processe. SLAS TECHNOLOGY: Translating Life Sciences Innovation. 2020;25(6):585–597. https://doi.org/10.1177/2472630320924999

[20]

Gijzen L., Marescotti D., Raineri E., et. al. An Intestine-on-a-Chip Model of Plug-and-Play Modularity to Study Inflammatory Processes // SLAS TECHNOLOGY: Translating Life Sciences Innovation. 2020. Vol. 25, no. 6. P. 585–597. https://doi.org/10.1177/2472630320924999

RIGHTS & PERMISSIONS

Tyukavin A.I., Arseniev N.А., Studneva M.A., Medvedeva V.S., Suchkov S.V.

AI Summary AI Mindmap
PDF

148

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/